Mark Puckett
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatitis Pathology and Treatment
- Parathyroid Disorders and Treatments
- Cancer Genomics and Diagnostics
- Gallbladder and Bile Duct Disorders
- Metabolism, Diabetes, and Cancer
- Nutrition and Health in Aging
- Esophageal and GI Pathology
University Hospitals Plymouth NHS Trust
2023-2024
Abstract Background Pancreatoduodenectomy (PD) is associated with significant postoperative morbidity. Surgeons should have a sound understanding of the potential complications for consenting and benchmarking purposes. Furthermore, preoperative identification high-risk patients can guide patient selection potentially allow targeted prehabilitation and/or individualized treatment regimens. Using large multicentre cohort, this study aimed to calculate incidence all PD identify risk factors....
Backgrounds/Aims: While the effects of myosteatosis are emerging, evidence for its use as a predictor outcomes in patients undergoing pancreatoduodenectomy (PD) still needs to be established.The study aims evaluate effect on shortand long-term PD.Methods: We analyzed short-and who underwent PD between July 2006 and May 2013.Myosteatosis was measured retrospectively from preoperative computed tomography (CT) at L3 vertebra level, dichotomized binary exposure variable < 38.5 Hounsfield unit...